New Pregabalin manufacturing process. The original manufacturing process for Pregabalin was inefficient and produced nonrecyclable enantiomer as a byproduct. This new manufacturing process enables recycling of enantiomer, increasing product yields and the life cycle of raw materials; this significantly reduces the amount of raw materials required and generated waste. It also requires less organic solvents that pose health concerns.
Inventor/Owner/Manufacturer/Supplier
Pfizer
Stage of Development
Category
Keywords
Image